Paclitaxel Drug-Coated Balloon Angioplasty for Medically Refractory Intracranial Atherosclerotic Disease: A US Single-Center Experience With the AGENT Balloon. [PDF]
Chaudhari A +9 more
europepmc +1 more source
Balloon Valvuloplasty and Angioplasty
openaire +1 more source
Paclitaxel drug-coated balloon angioplasty for de novo coronary lesions in an expanded real world clinical setting: the multicenter ALLIANCE registry. [PDF]
Nakamura M +19 more
europepmc +1 more source
Intraoperative balloon angioplasty
G J Murphy, J N Johnson
openaire +1 more source
Value-based approach to AVF maintenance: institutional micro-costing of drug-coated versus plain balloon angioplasty in a fixed-reimbursement system. [PDF]
Lučev J +3 more
europepmc +1 more source
Clinical outcomes of directional atherectomy versus plain balloon angioplasty as vessel preparation prior to drug-coated balloon treatment for femoropopliteal occlusive disease. [PDF]
Wang X +9 more
europepmc +1 more source
Coronary Artery Aneurysm Post Drug-Coated Balloon Angioplasty. [PDF]
Saboe A +3 more
europepmc +1 more source
Patient-specific computational fluid dynamics analysis of portal vein hemodynamics before and after balloon angioplasty following living donor liver transplantation: a proof-of-concept study. [PDF]
Yang F, Peng C, Luo Y, Xiao H, Ma L.
europepmc +1 more source
Long-Term Efficacy of Drug-Coated Balloon Angioplasty vs. Drug-Eluting Stent for De Novo Large-Vessel Coronary Arteries. [PDF]
Masuda M +6 more
europepmc +1 more source
Plain balloon angioplasty with or without bare-metal stenting versus drug-coated balloon angioplasty with or without bare-metal stenting versus primary drug-eluting stenting in patients requiring femoropopliteal, with or without infrapopliteal, endovascular revascularization for chronic limb-threatening ischaemia: BASIL-3 within-trial health economic analysis. [PDF]
Javed M +10 more
europepmc +1 more source

